Clinical Trials Browser

Interventional × Drug Combinations × Clear all

NCT07220616 2026-03-18

A First-in-Human Trial of DS3790a in Participants With Hematological Malignancies

Phase 1/2 Recruiting

Other hematologic neoplasm

Hematologic Neoplasms

NCT04786600 2025-07-01

A Phase II Randomized Therapeutic Optimization Trial for Subjects With Refractory Metastatic Colorectal Cancer Using ctDNA: Rapid 1 Trial

Phase 2 Terminated

6 enrolled 11 charts

Gastrointestinal

Colorectal Neoplasms

NCT04983745 2023-12-21

DIDO

Phase 2 Unknown

Other solid neoplasm

Homologous Recombination Deficient Solid Tumors

NCT04138381 2023-03-27

SeliGIST

Phase 1/2 Unknown

Neoplasm Metastasis, Sarcoma, Drug-Related Side Effects and Adverse Reactions

NCT03977272 2023-01-27

Combination of Anti-PD-1 Antibody and Chemotherapy in Metastatic Pancreatic Cancer

Phase 2 Completed

Gastrointestinal

Pancreatic Neoplasms

NCT04389086 2022-09-06

PelvEx II

Phase 3 Recruiting

Gastrointestinal

Margins of Excision, Rectal Neoplasms

NCT04125693 2022-04-01

Roll-over Study to Continue Treatment With the Investigational Drug Rogaratinib and to Further Test Its Safety

Phase 2 Completed

BreastGenitourinaryHead & NeckThoracic

Acrocephalosyndactylia, Breast Neoplasms, Carcinoma, Non-Small-Cell Lung, Carcinoma, Transitional Cell, Head and Neck Neoplasms, Neoplasms, Small Cell Lung Carcinoma

NCT04065308 2019-08-22

Dara_DCEP

Phase 2 Unknown

Plasmacytoma

NCT02882269 2016-08-30

Neoadjuvant Chemotherapy for the Treatment of Resectable Locally Advanced Colon Cancer

Phase 2/3 Unknown

Gastrointestinal

Colonic Neoplasms